SIREN : 340256619
GSA HEALTHCARE is a French company founded 39 years ago, specialized in the sector Activités des agences de publicité. Based in PARIS (75015), this company of category ETI shows in 2024 a revenue of 48.7 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 48 746 446 € | 40 470 508 € | 44 041 432 € | 34 779 651 € | 28 845 506 € | 29 036 284 € | 30 423 696 € | 32 288 667 € | 32 138 589 € |
| Net income | 235 502 € | -229 163 € | 757 739 € | 656 722 € | 462 481 € | 612 034 € | 303 074 € | 1 015 781 € | 33 553 € |
| EBITDA | 627 118 € | 100 021 € | 1 373 766 € | 1 076 221 € | 912 260 € | 213 830 € | -1 012 806 € | 915 665 € | -126 717 € |
| Net margin | 0.5% | -0.6% | 1.7% | 1.9% | 1.6% | 2.1% | 1.0% | 3.1% | 0.1% |
In 2024, GSA HEALTHCARE achieves revenue of 48.7 M€. Over the period 2016-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +5.3%. Vs 2023, growth of +20% (40.5 M€ -> 48.7 M€). After deducting consumption (5.5 M€), gross margin stands at 43.2 M€, i.e. a rate of 89%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 627 k€, representing 1.3% of revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 236 k€, i.e. 0.5% of revenue. This profit can be retained or distributed to shareholders.
48 746 446 €
43 236 621 €
627 118 €
764 133 €
235 502 €
1.3%
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 29%. The balance between equity and debt is satisfactory. Cash flow represents 0.2% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.
0.0%
29.352%
0.208%
0.0
26.1%
In 2024, the debt ratio of GSA HEALTHCARE (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
In 2024, the financial autonomy of GSA HEALTHCARE (29.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2024, the repayment capacity of GSA HEALTHCARE (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 122.00. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 0.7x. Danger: operating income does not cover interest charges, unsustainable situation.
122.003
0.688
In 2024, the liquidity ratio of GSA HEALTHCARE (122.00) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
In 2024, the interest coverage of GSA HEALTHCARE (0.7x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 83 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 44 days. The gap of 39 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Inventory turnover is 9 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 43 days of revenue, i.e. 5.8 M€ to permanently finance. Over 2016-2024, WCR increased by +1197%, requiring additional financing.
5 836 899 €
83 j
44 j
9 j
43 j
Based on 68 transactions of similar company sales
(all years),
the value of GSA HEALTHCARE is estimated at
4 320 583 €
(range 1 686 303€ - 9 650 017€).
With an EBITDA of 627 118€, the sector multiple of 2.9x is applied.
The price/revenue ratio is 0.22x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 68 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare GSA HEALTHCARE with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des agences de publicité
The revenue of GSA HEALTHCARE in 2024 is 48.7 M€.
Yes, GSA HEALTHCARE generated a net profit of 236 k€ in 2024.
The headquarters of GSA HEALTHCARE is located in PARIS (75015), in the department Paris.
The tax return of GSA HEALTHCARE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
GSA HEALTHCARE operates in the sector Activités des agences de publicité (NAF code 73.11Z). See the 'Sector positioning' section above to compare the company with its competitors.